T2 Biosystems Revenue vs. Price To Sales
| TTOODelisted Stock | USD 0.18 0.05 21.74% |
For T2 Biosystems profitability analysis, we use financial ratios and fundamental drivers that measure the ability of T2 Biosystems to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well T2 Biosystems utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between T2 Biosystems's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of T2 Biosystems over time as well as its relative position and ranking within its peers.
TTOO |
T2 Biosystems Price To Sales vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining T2 Biosystems's current stock value. Our valuation model uses many indicators to compare T2 Biosystems value to that of its competitors to determine the firm's financial worth. T2 Biosystems is rated below average in revenue category among its peers. It is rated below average in price to sales category among its peers . The ratio of Revenue to Price To Sales for T2 Biosystems is about 10,363,060 . Comparative valuation analysis is a catch-all model that can be used if you cannot value T2 Biosystems by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for T2 Biosystems' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.TTOO Revenue vs. Competition
T2 Biosystems is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 78.09 Billion. T2 Biosystems adds roughly 7.19 Million in revenue claiming only tiny portion of equities under Health Care industry.
TTOO Price To Sales vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
T2 Biosystems |
| = | 7.19 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
T2 Biosystems |
| = | 0.69 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
TTOO Price To Sales Comparison
T2 Biosystems is currently under evaluation in price to sales category among its peers.
T2 Biosystems Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in T2 Biosystems, profitability is also one of the essential criteria for including it into their portfolios because, without profit, T2 Biosystems will eventually generate negative long term returns. The profitability progress is the general direction of T2 Biosystems' change in net profit over the period of time. It can combine multiple indicators of T2 Biosystems, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts. T2 Biosystems operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 182 people.
TTOO Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on T2 Biosystems. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of T2 Biosystems position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the T2 Biosystems' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in T2 Biosystems without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Use Investing Themes to Complement your T2 Biosystems position
In addition to having T2 Biosystems in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banking Thematic Idea Now
Banking
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banking theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banking Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in TTOO Pink Sheet
If you are still planning to invest in T2 Biosystems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystems' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |